Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|August 26, 2024

Pharma Pulse 8/26/24: BioAge Appoints Former GSK CEO to Board of Directors, Addressing Challenges to Access & more

The latest news for pharma industry insiders.

Addressing Challenges to Access, Advancement of Myeloma Therapies

In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, MD, chief medical officer, IMF, discusses challenges of access and advancement of myeloma therapies.

PCPs and Quality: Too Much of a Measured Thing

Research published today in JAMA Health Forum Shows primary care physicians faced an average of 57 quality measures. The authors argue that many may interfere with care improvement and contribute to physician burnout.

Are You Mentally Fit to Lead? AI Has Thoughts

Artificial intelligence could soon be used to suggest executives are in cognitive decline—and help them ward off scrutiny.

BioAge Appoints Former GSK CEO Jean-Pierre Garnier as Chair of Its Board of Directors

New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development.

ACG World on LinkedIn

At ACG, we believe that establishing long-term sustainability goals is essential for securing a resilient future. Through our strategic partnerships and dedicated focus on decarbonization, we're making significant strides in reducing carbon emissions and championing sustainable practices. Together, we can build a greener, more sustainable world.
We invite you to explore more about our journey and vision in an article by our CEO of Packaging Materials,Shivshankar S.R. - https://lnkd.in/dAmxqMhJ

#Sustainability #NetZero #CorporateResponsibility #GreenManufacturing #Innovation #MakeItBetter Pharmaceutical Commerce Magazine

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.